bioRxiv · 10.1101/2021.01.26.428255
The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome
Abstract
Despite the involvement of Poly(ADP-ribose) polymerase-1 (PARP1) in many important biological pathways, the target residues of PARP1-mediated ADP-ribosylation remain ambiguous. To explicate the ADP-ribosylation regulome, we analyzed human cells depleted for key regulators of PARP1 activity, histone PARylation factor 1 (HPF1) and ADP-ribosylhydrolase 3 (ARH3). Using quantitative proteomics, we quantified 1,596 ADPr sites, displaying a thousand-fold regulation across investigated knockout cells. We find that HPF1 and ARH3 inversely and homogenously regulate the serine ADP-ribosylome on a proteome-wide scale with consistent adherence to lysine-serine (KS)-motifs suggesting targeting is independent of HPF1 and ARH3. Our data reveal that ADPr globally exists as mono-ADP-ribosylation, and we detail a remarkable degree of histone co-modification with ADPr and other post-translational modifications. Strikingly, no HPF1-dependent target residue switch from serine to glutamate/aspartate was detectable in cells, which challenges current dogma related to PARP1 target residues. Collectively, we elucidate hitherto unappreciated processes related to cellular PARP1 activity.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Hendriks, I. A., Buch-Larsen, S. C., Prokhorova, E., Rebak, A. K. L. F. S., Ahel, I., Nielsen, M. L.. 2021-01-27. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome. https://doi.org/10.1101/2021.01.26.428255
Cite the original work for its findings. Save a collection to share your selection of sources.